Old Web
English
Sign In
Acemap
>
authorDetail
>
Camille Orman
Camille Orman
Anesthesia
Medicine
Placebo
Adverse effect
Psychology
4
Papers
129
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
2021
Patient Preference and Adherence
Gang Li
Alexander Keenan
Mehmet Daskiran
Maju Mathews
Isaac Nuamah
Camille Orman
Kruti Joshi
Arun S. Singh
Annabelle Godet
Katalin Pungor
Srihari Gopal
Show All
Source
Cite
Save
Citations (0)
Development and preliminary validation of an integrated efficacy-tolerability composite measure for the evaluation of analgesics.
2015
Pain
Nathaniel P. Katz
Joy Mou
Jeremiah J. Trudeau
Jim Xiang
G. Vorsanger
Camille Orman
Myoung Kim
Show All
Source
Cite
Save
Citations (3)
Long-Term Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Titration, 1-Year Study
2011
Journal of Clinical Psychopharmacology
Lenard A. Adler
Camille Orman
H. Lynn Starr
Steve Silber
Joseph Palumbo
Kimberly M. Cooper
Joris Berwaerts
Diane D. Harrison
Show All
Source
Cite
Save
Citations (38)
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
2009
Journal of Clinical Psychopharmacology
Lenard A. Adler
Brenda Zimmerman
H. Lynn Starr
Steve Silber
Joseph Palumbo
Camille Orman
Thomas J. Spencer
Show All
Source
Cite
Save
Citations (88)
1